VSVladimir B. Sergienko

Vladimir B. Sergienko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vladimir B. Sergienko has a total of 154 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Focal Artifacts and Extraorgan Findings in Pulmonary Perfusion Scintigraphy

    by S. P. Mironov, M. Е. Bugriy, V. B. Sergienko

    Objective : to clarify and systematize the causes of focal and non-organ artifacts capable of acting as diagnostic pitfalls in lung perfusion scintigraphy using 99mTc macroaggregated albumin (MAA), as well as their semiotics, principles, and methods for differentiating from pathological changes. Material and methods. The outcomes of lung perfusion scintigraphy were analyzed in 1,025 patients who underwent examinations to rule out pulmonary embolism (PE) or thromboembolic factors contributing to diagnosed pulmonary hypertension. The procedure was carried out in a multiplanar mode using twodetector single-photon emission computed tomography (SPECT) scanners while the patient was lying supine, 4–5 minutes after intravenous injection of a radiopharmaceutical (RPh) with an activity level of 111–148 MBq. Lung images were captured in six projections, including anterior, posterior, and four oblique planes. If required, additional screening was performed in combined SPECT/CT mode. The term “artifact” was used to describe isolated perfusion defects that simulate PE, as well as extrapulmonary findings resembling signs of a right-to-left shunt. Results . Artefact scintigraphic findings corresponding to the above criteria were found in 634 (61.8%) patients. Focal changes (n=618) were classified into “cold” and “hot” based on their scintigraphic presentation. Single “cold” lesions (n=611) were most commonly due to the shielding effect of altered anatomical structures (heart – 493, pulmonary artery trunk – 72, pleural effusion and elevated diaphragm – 41), as well as implanted pacemakers (n=5). “Hot spot” (n=7) obscured thromboembolic perfusion defects because of their high specific radioactivity. The main reason for this artifact is blood ingress into a syringe with 99mTc-MAA during intravenous administration of RPh. Extrapulmonary signs of right-to-left shunt were observed in 14 patients with congenital heart defects and were characterized by concurrent visualization of the kidneys and other organs in the systemic circulation (spleen, liver, thyroid gland). The reason for artefactual intestinal imaging (n=2) was residual radioactivity following prior myocardial perfusion scintigraphy with 99mTc methoxyisobutyl-isonitrile. Conclusion. Examining the reasons behind the occurrence of focal and extra-organ artifact findings in lung perfusion scintigraphy, as well as associated diagnostic and interpretive pitfalls, will enable the development of an appropriate quality control strategy to reduce the likelihood of false-positive interpretations of PE and systemic pulmonary shunts.

  • Open Access

    95 Years Since the Birth of Professor Yu.N. Kasatkin, the Talented Pedagogue and Scientist in the Field of Nuclear Medicine

    by S. P. Mironov, V. B. Sergienko

    Yuri N. Kasatkin is a famous scientist in the field of nuclear medicine, the pioneer of introducing and using scintigraphy methods in domestic clinical practice. As a talented organizer and teacher, he headed the Department of Medical Radiology at the Central Institute for Advanced Medical Studies for 35 years and was the its Vice-Rector for Academic Affairs. He made a great contribution to the formation of a postgraduate training system for specialists in radionuclide diagnostics and healthcare in general. The individual components of this organizational and pedagogical work are considered in this work.

  • Open Access

    130 Years Since the Birth of Professor V.K. Modestov, the Founder of the First Medical Radiology Department

    by Sergey P. Mironov, Vladimir B. Sergienko

    Vasily Kornilovich Modestov is an iconic figure of medical science. His achievements include the establishment of the resort destination in the Urals, the development of Russian balneology and radiobalneology, and a number of important inventions and proposals that preserved the health of many soldiers during the Great Patriotic War. However, even among radiologists, the role of V.K. Modestov as an organizer of the country's first Medical Radiology Department in the development of diagnostic and therapeutic use of open radioactive isotopes is little known. In an attempt to correct this injustice, the authors consider the origins of Medical Radiology Department, the main stages of its formation under the leadership of V.K. Modestov.


  • Open Access

    Role of 99mTc-pyrophosphate myocardial scintigraphy in assessing the efficiency of tafamidis therapy: a case series

    by A. A. Shoshina, A. A. Ansheles, S. N. Nasonova, I. V. Zhirov, V. B. Sergienko, S. N. Tereshchenko

    Introduction. In recent years, the detection rate of transthyretin amyloid cardiomyopathy has been rapidly increasing. The only drug registered as a pathogenetic therapy in Russia is tafamidis. To date, there is no single protocol for assessing disease progression, and the role of scintigraphy with phosphate complexes is not reflected in current documents due to the lack of evidence.Brief description. The article presents a case series including patients who received tafamidis therapy for at least 12 months. During therapy, there were no signs of disease progression, and in some cases, according to myocardial scintigraphy with phosphate complexes, a decrease in radiopharmaceutical uptake was noted.Discussion. The role of myocardial scintigraphy with phosphate complexes for monitoring the effectiveness of tafamidis therapy was discussed.


  • Open Access

    Improvement of the technique of positioning the endocardial electrodes of the cardiac contractility modulation device in patients with CHF with reduced ejection fraction and atrial fibrillation

    by Alfiya A. Safiullina, Tatiana M. Uskach, Oleg V. Sapelnikov, Marina A. Saidova, Alexey A. Ansheles, Vladimir B. Sergienko, Valeria A. Amanatova, Igor R. Grishin, Dmitry I. Cherkashin, Renat S. Akchurin, et al.

    Aim. To evaluate the efficacy and safety of the advanced technique for positioning the endocardial electrodes of a cardiac contractility modulation (CCM) device. Materials and methods. The CCM system was implanted in 100 patients, of which 60 CCM electrodes were positioned in the most optimal zones of myocardial perfusion, in particular, in the zone of the minor focal-scar/fibrotic lesion (the Summed Rest Score of 0 to 1–2, the intensity of the radiopharmaceutical at least 30%), and in 40 patients according to the standard procedure. Before the implantation of the CCM system, 60 patients underwent tomography (S-SPECT) of the myocardium with 99mTc-methoxy-isobutyl-isonitrile at rest to determine the most optimal electrode positioning zones and 100 patients underwent transthoracic echocardiography at baseline and after 12 months to assess the effectiveness of surgical treatment. Results. Improved ventricular electrode positioning technique is associated with the best reverse remodeling of the left ventricular myocardium, especially in patients with ischemic chronic heart failure, with less radiation exposure to the surgeon and the patient, and without electrode-related complications. Conclusion. At the preoperative stage, it is recommended to perform a synchronized single-photon emission computed tomography of the myocardium with 99mTc-methoxy-isobutyl-isonitrile at rest before implantation of the CCM device to assess the presence of scar zones/myocardial fibrosis in the anterior and inferior septal regions of the interventricular septum of the left ventricle, followed by implantation of ventricular electrodes in the zone of the minor scar/fibrous lesion, which will allow to achieve optimal stimulation parameters, increase the effectiveness of CCM therapy, reduce the radiation exposure on medical personnel and the patient during surgery.


  • Open Access

    Expert Center for cardiac amyloidosis: reality and perspectives

    by Svetlana Nasonova, Igor Zhirov, Anastasiya Shoshina, Yulia Osmolovskaya, Alexey Ansheles, Olga Tchaikovskaya, Svetlana Dobrovolskaya, Vladimir Sergienko, Marina Saidova, Sergey Tereshchenko, et al.

    Aim. To evaluate the features of diagnosis of amyloid cardiomyopathy (ACMP), differential diagnosis of different types of amyloidosis and its clinical manifestations. Materials and methods. Were analyzed 150 cases of patients who consulted at the Expert Center for Amyloidosis with suspicion of the presence of ACMP. 63 patients were diagnosed with ACMP: 25 (39.7%) – women, 38 (60.3%) – men, with an average age of 64.1±1.5. 36 (57.1%) patients had AL-amyloidosis (immunoglobulin amyloid light-chain amyloidosis), 25 (39.7%) – ATTR-amyloidosis (transthyretin amyloidosis), 2 (3.2%) – AA-amyloidosis with heart failure (reactive systemic amyloidosis caused by hypersecretion of á-globulin). The analysis of clinical manifestations depending on the type of amyloidosis, data of laboratory and instrumental methods of diagnosis is carried out. Results. In most cases, 53 (84.1%) patients, amyloidosis manifested as signs of heart failure. Among cardiac manifestations, shortness of breath (95.2%), general weakness (93.7%), lower limb edema (76.2%) were the most common. To confirm the diagnosis, despite the high accuracy of the speckle-tracking echocardiography and magnetic resonance imaging of the heart with gadolinium, in rare cases a biopsy is required (e.g. there is a combination of clinical signs of several types of amyloidosis). Biopsy of the affected organ was performed in 31 (49.2%) patients. The strategy for further pathogenetic treatment depends on the determination of the type of amyloidosis. Free light chains of immunoglobulins were detected in 57.1% of cases, which allowed diagnosis of AL-amyloidosis. In 17 (38.6%) patients myocardial scintigraphy with 99mTc-pyrophosphate showed signs of ATTR-amyloidosis, which with a negative result of immunochemical studies allows non-invasive diagnosis of it. Conclusion. ACMP is a disease with an extremely adverse prognosis. Raising the awareness of specialists about ACMP is an important goal. With timely diagnosis, pathogenetic therapy can be started early, which will improve the quality of life and prognosis of patients with ACMP.


  • Sympathetic innervation of the left ventricle in patients with myocardial infarction in acute and long-term period

    by V.N. Shitov, L.E. Samoilenko, I.N. Merkulova, V.B. Sergienko

    Objective. To study regional sympathetic activity of the left ventricle using single-photon emission tomography (SPECT) with I123-labeled metaiodobenzylguanidine (I123-MIBG) compared to perfusion changes according to 99mTc SPECT data in acute and long-term period of myocardial infarction. Material and methods. The study included 52 people with new anterior or inferior MI and no other conditions potentially leading to regional disturbances in sympathetic activity of the heart. All patients underwent SPECT with I123-labeled metaiodobenzylguanidine and Technetium [99mTc] within a week and 8 months after MI. Results. Regional disturbances of sympathetic activity of the left ventricle corresponded to perfusion disturbance zone, but they were larger. In most patients, perfusion disturbance zone decreased after 8 months from 23% (13; 32) to 19% (5; 30) (p<0.001) compared to acute period. The area of impaired sympathetic activity decreased from 34% (24; 40) to 27% (22; 36) (p<0.05). Changes in sympathetic innervation and myocardial perfusion over time were unidirectional in more than 70% of patients. In addition, there was a correlation between zones of myocardial perfusion and innervation disorders with LV ejection fraction, as well as myocardial innervation with cardiac chamber dimensions. Conclusion. Regional sympathetic disorders in MI are largely determined by perfusion changes and correlate with LV ejection fraction and remodeling in long-term period. Severe disorders of sympathetic innervation with smaller zone of perfusion changes in long-term period can indicate viable myocardium in peri-infarction zone.


  • Open Access

    Dynamic Hepatocholescintigraphy with Bromesida® 99mTc

    by S. P. Mironov, V. B. Sergienko

    Hepatobiliary scintigraphy using radiopharmaceuticals (RPh) labeled with short-lived technetium‑99m (99mТс) has been used since the mid‑1970s and still retains its diagnostic value. The lecture focuses on key aspects of the pharmacokinetics of lidocaine analogs based on N-substitutions of iminodiacetic acid. The methodology and diagnostic significance of hepatocholescintigraphy with Bromesida® 99mTс (mebrofenin), including computer registration of RPh passage, anatomical and functional characteristics of liver, bile ducts, gallbladder and duodenum, are considered. Scintigraphic semiotics in choledochal cysts, acute and chronic cholecystitis, gallbladder and duodenum dyskinesia, are discussed. The presented clinical case illustrates the possibilities of Bromesida® 99mTс scintigraphy in the gallbladder form anomaly.

  • Open Access

    Virtual platform for computer simulation of radionuclide imaging in nuclear cardiology: Comparison with clinical data

    by Natalya V. Denisova, Mikhail A. Gurko, Inna P. Kolinko, Alexey A. Ansheles, Vladimir B. Sergienko

    BACKGROUND: In radionuclide imaging, in vivo human clinical studies are limited because of radiation exposure and ethical concerns; therefore, mathematical modeling and in silico computer simulations based on digital models are becoming increasingly important. In the English-language literature, this approach is called “virtual clinical trials.” AIMS: This study aimed to develop software tools for the simulation of radionuclide visualization of myocardial perfusion by single-photon emission computed tomography combined with computed tomography using 99mTc-MIBI as the radiopharmaceutical and perform studies aimed at improving the accuracy of single-photon emission computed tomography. MATERIALS AND METHODS: A software package “Virtual platform for simulations of single-photon emission computed tomography combined with computed tomography method in nuclear cardiology” was developed using digital patient models, a scanner, and assessment of the state of the myocardium using digital images of the left ventricle in the form of a “polar map.” Verification of the software package was performed by comparison with clinical data obtained at the National Medical Research Center of Cardiology Named After Academician E.I. Chazov (Moscow). Simulation computer tests were performed, in which the accuracy of assessing the state of the myocardium was assessed, depending on the approach to normalizing the polar map and corrective factors in the reconstruction algorithm. RESULTS: The results of the simulation tests revealed that the assessment of left ventricular myocardial perfusion significantly depended on the method of normalizing the polar map and considered corrective factors in the reconstruction algorithm. The most accurate estimates were obtained by calculating the normalization coefficient from the average value of activity in the normal zone of the myocardium. The common approach to pixel normalization with maximum intensity can lead to errors. The results of the virtual trials were fully consistent with clinical observations. CONCLUSIONS: The transition from relative normalized values of activity in the myocardium to absolute quantitative estimates may eliminate existing limitations and uncertainties and is the main condition for improving the diagnostic accuracy of single-photon emission computed tomography combined with computed tomography in nuclear cardiology.


  • Open Access

    Difficulties in differential diagnosis of the AL- and ATTR-cardiac amyloidosis. Case report

    by F I Orlov, A A Ansheles, S N Nasonova, M A Saidova, I V Zhirov, E A Stepanova, M Y Suvorina, A A Shoshina, S N Tereshchenko, V B Sergienko

    The article presents a clinical case describing a complex differential diagnosis of cardiac amyloidosis types and verification of the diagnosis of AL-amyloidosis.